CA2853910A1 - Isolating and therapeutic use of perivascular medicinal cells - Google Patents

Info

Publication number

CA2853910A1

CA2853910A1 CA2853910A CA2853910A CA2853910A1 CA 2853910 A1 CA2853910 A1 CA 2853910A1 CA 2853910 A CA2853910 A CA 2853910A CA 2853910 A CA2853910 A CA 2853910A CA 2853910 A1 CA2853910 A1 CA 2853910A1

Authority

CA

Canada

Prior art keywords

bone

pvmcs

blood vessel

umbilical cord

cord blood

Prior art date

2011-08-29

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 230000001225 therapeutic effect Effects 0.000 title description 24
• 210000000988 bone and bone Anatomy 0.000 claims abstract description 624
• 238000000034 method Methods 0.000 claims abstract description 200
• 210000004700 fetal blood Anatomy 0.000 claims abstract description 192
• 239000000203 mixture Substances 0.000 claims abstract description 139
• 238000004519 manufacturing process Methods 0.000 claims abstract description 26
• 230000003248 secreting effect Effects 0.000 claims abstract description 15
• 230000001228 trophic effect Effects 0.000 claims abstract description 15
• 230000001419 dependent effect Effects 0.000 claims abstract description 14
• 201000010099 disease Diseases 0.000 claims abstract description 10
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 10
• 230000003915 cell function Effects 0.000 claims abstract description 5
• 210000004027 cell Anatomy 0.000 claims description 206
• 102000004190 Enzymes Human genes 0.000 claims description 125
• 108090000790 Enzymes Proteins 0.000 claims description 125
• 238000002360 preparation method Methods 0.000 claims description 104
• 239000000243 solution Substances 0.000 claims description 97
• 210000001519 tissue Anatomy 0.000 claims description 73
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 66
• 239000002953 phosphate buffered saline Substances 0.000 claims description 66
• 239000000463 material Substances 0.000 claims description 62
• 239000002609 medium Substances 0.000 claims description 61
• 239000006285 cell suspension Substances 0.000 claims description 60
• -1 GAGases Proteins 0.000 claims description 57
• 210000001185 bone marrow Anatomy 0.000 claims description 57
• 239000012981 Hank's balanced salt solution Substances 0.000 claims description 49
• 210000004204 blood vessel Anatomy 0.000 claims description 47
• 239000012594 Earle’s Balanced Salt Solution Substances 0.000 claims description 46
• 230000006862 enzymatic digestion Effects 0.000 claims description 45
• 239000007758 minimum essential medium Substances 0.000 claims description 44
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 44
• 239000003656 tris buffered saline Substances 0.000 claims description 44
• 102100032912 CD44 antigen Human genes 0.000 claims description 41
• 102100037241 Endoglin Human genes 0.000 claims description 39
• 239000012634 fragment Substances 0.000 claims description 39
• 101000881679 Homo sapiens Endoglin Proteins 0.000 claims description 38
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 37
• 230000006378 damage Effects 0.000 claims description 36
• 102100022464 5'-nucleotidase Human genes 0.000 claims description 34
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims description 34
• 238000005119 centrifugation Methods 0.000 claims description 34
• 210000002469 basement membrane Anatomy 0.000 claims description 32
• 108090000623 proteins and genes Proteins 0.000 claims description 31
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 30
• 239000003855 balanced salt solution Substances 0.000 claims description 30
• 235000018102 proteins Nutrition 0.000 claims description 30
• 102000004169 proteins and genes Human genes 0.000 claims description 30
• 239000011780 sodium chloride Substances 0.000 claims description 29
• 102000029816 Collagenase Human genes 0.000 claims description 28
• 108060005980 Collagenase Proteins 0.000 claims description 28
• 230000003115 biocidal effect Effects 0.000 claims description 28
• 102000035195 Peptidases Human genes 0.000 claims description 27
• 108091005804 Peptidases Proteins 0.000 claims description 27
• APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 26
• OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 26
• BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 claims description 26
• 239000004365 Protease Substances 0.000 claims description 25
• 229960005322 streptomycin Drugs 0.000 claims description 25
• 210000000689 upper leg Anatomy 0.000 claims description 25
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 24
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 24
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 24
• 239000000427 antigen Substances 0.000 claims description 24
• 108091007433 antigens Proteins 0.000 claims description 24
• 102000036639 antigens Human genes 0.000 claims description 24
• 239000007975 buffered saline Substances 0.000 claims description 24
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 23
• 239000007995 HEPES buffer Substances 0.000 claims description 23
• 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 22
• 102000005741 Metalloproteases Human genes 0.000 claims description 22
• 108010006035 Metalloproteases Proteins 0.000 claims description 22
• 239000000515 collagen sponge Substances 0.000 claims description 22
• 229920000642 polymer Polymers 0.000 claims description 22
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims description 21
• 239000000919 ceramic Substances 0.000 claims description 21
• 210000000963 osteoblast Anatomy 0.000 claims description 21
• 210000000130 stem cell Anatomy 0.000 claims description 21
• 210000005009 osteogenic cell Anatomy 0.000 claims description 20
• 101710155857 C-C motif chemokine 2 Proteins 0.000 claims description 19
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 19
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 19
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 19
• 108010005843 Cysteine Proteases Proteins 0.000 claims description 18
• 102000005927 Cysteine Proteases Human genes 0.000 claims description 18
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 18
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 18
• 108090001007 Interleukin-8 Proteins 0.000 claims description 18
• 239000003242 anti bacterial agent Substances 0.000 claims description 18
• 229940096397 interleukin-8 Drugs 0.000 claims description 18
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 claims description 18
• 230000004048 modification Effects 0.000 claims description 18
• 238000012986 modification Methods 0.000 claims description 18
• 210000003462 vein Anatomy 0.000 claims description 18
• 239000011324 bead Substances 0.000 claims description 17
• 239000001506 calcium phosphate Substances 0.000 claims description 17
• 102000012479 Serine Proteases Human genes 0.000 claims description 16
• 108010022999 Serine Proteases Proteins 0.000 claims description 16
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims description 16
• 230000002519 immonomodulatory effect Effects 0.000 claims description 16
• 210000002303 tibia Anatomy 0.000 claims description 16
• 102100024210 CD166 antigen Human genes 0.000 claims description 15
• 102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 claims description 15
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 15
• 229930182566 Gentamicin Natural products 0.000 claims description 15
• 101000623903 Homo sapiens Cell surface glycoprotein MUC18 Proteins 0.000 claims description 15
• 102000004058 Leukemia inhibitory factor Human genes 0.000 claims description 15
• 108090000581 Leukemia inhibitory factor Proteins 0.000 claims description 15
• 108090001092 clostripain Proteins 0.000 claims description 15
• 239000003480 eluent Substances 0.000 claims description 15
• 229960002518 gentamicin Drugs 0.000 claims description 15
• 108091005658 Basic proteases Proteins 0.000 claims description 14
• 101000980840 Homo sapiens CD166 antigen Proteins 0.000 claims description 14
• 102000004889 Interleukin-6 Human genes 0.000 claims description 14
• 108090001005 Interleukin-6 Proteins 0.000 claims description 14
• 102100021592 Interleukin-7 Human genes 0.000 claims description 14
• 108010002586 Interleukin-7 Proteins 0.000 claims description 14
• 230000003511 endothelial effect Effects 0.000 claims description 14
• 230000012010 growth Effects 0.000 claims description 14
• 229940100601 interleukin-6 Drugs 0.000 claims description 14
• 229940100994 interleukin-7 Drugs 0.000 claims description 14
• 108010008951 Chemokine CXCL12 Proteins 0.000 claims description 13
• 230000002378 acidificating effect Effects 0.000 claims description 13
• 230000007935 neutral effect Effects 0.000 claims description 13
• 239000008194 pharmaceutical composition Substances 0.000 claims description 13
• 230000001105 regulatory effect Effects 0.000 claims description 13
• 230000001502 supplementing effect Effects 0.000 claims description 13
• 102100032366 C-C motif chemokine 7 Human genes 0.000 claims description 12
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 claims description 12
• 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 claims description 12
• 102100037852 Insulin-like growth factor I Human genes 0.000 claims description 12
• 108700018351 Major Histocompatibility Complex Proteins 0.000 claims description 12
• 102100035194 Placenta growth factor Human genes 0.000 claims description 12
• 230000033115 angiogenesis Effects 0.000 claims description 12
• 210000001367 artery Anatomy 0.000 claims description 12
• 229910000389 calcium phosphate Inorganic materials 0.000 claims description 12
• 235000011010 calcium phosphates Nutrition 0.000 claims description 12
• 108020004201 indoleamine 2,3-dioxygenase Proteins 0.000 claims description 12
• 102000006639 indoleamine 2,3-dioxygenase Human genes 0.000 claims description 12
• 210000000614 rib Anatomy 0.000 claims description 12
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 claims description 12
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 12
• 238000005406 washing Methods 0.000 claims description 12
• APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims description 11
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims description 11
• 101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 claims description 11
• 206010054094 Tumour necrosis Diseases 0.000 claims description 11
• 229960003942 amphotericin b Drugs 0.000 claims description 11
• 239000005312 bioglass Substances 0.000 claims description 11
• 238000004113 cell culture Methods 0.000 claims description 11
• 210000002758 humerus Anatomy 0.000 claims description 11
• 210000004417 patella Anatomy 0.000 claims description 11
• 210000001991 scapula Anatomy 0.000 claims description 11
• 102100023688 Eotaxin Human genes 0.000 claims description 10
• 101710139422 Eotaxin Proteins 0.000 claims description 10
• 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 10
• 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 10
• 102000011923 Thyrotropin Human genes 0.000 claims description 10
• 108010061174 Thyrotropin Proteins 0.000 claims description 10
• 210000003109 clavicle Anatomy 0.000 claims description 10
• 238000012258 culturing Methods 0.000 claims description 10
• 239000003937 drug carrier Substances 0.000 claims description 10
• 238000001914 filtration Methods 0.000 claims description 10
• 230000011164 ossification Effects 0.000 claims description 10
• 238000004062 sedimentation Methods 0.000 claims description 10
• 102100021935 C-C motif chemokine 26 Human genes 0.000 claims description 9
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims description 9
• 108010055124 Chemokine CCL7 Proteins 0.000 claims description 9
• 230000006907 apoptotic process Effects 0.000 claims description 9
• XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical group CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims description 9
• 230000011278 mitosis Effects 0.000 claims description 9
• 102000013462 Interleukin-12 Human genes 0.000 claims description 8
• 108010065805 Interleukin-12 Proteins 0.000 claims description 8
• 102000049772 Interleukin-16 Human genes 0.000 claims description 8
• 101800003050 Interleukin-16 Proteins 0.000 claims description 8
• 108010009474 Macrophage Inflammatory Proteins Proteins 0.000 claims description 8
• 102000009571 Macrophage Inflammatory Proteins Human genes 0.000 claims description 8
• 210000002798 bone marrow cell Anatomy 0.000 claims description 8
• 238000011010 flushing procedure Methods 0.000 claims description 8
• 238000000227 grinding Methods 0.000 claims description 8
• 210000003692 ilium Anatomy 0.000 claims description 8
• 229940117681 interleukin-12 Drugs 0.000 claims description 8
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 7
• 102000003814 Interleukin-10 Human genes 0.000 claims description 7
• 108090000174 Interleukin-10 Proteins 0.000 claims description 7
• 239000004068 calcium phosphate ceramic Substances 0.000 claims description 7
• 229940076144 interleukin-10 Drugs 0.000 claims description 7
• 210000000265 leukocyte Anatomy 0.000 claims description 7
• 229910052751 metal Inorganic materials 0.000 claims description 7
• 239000002184 metal Substances 0.000 claims description 7
• 102100036850 C-C motif chemokine 23 Human genes 0.000 claims description 6
• 101710098275 C-X-C motif chemokine 10 Proteins 0.000 claims description 6
• 108010083698 Chemokine CCL26 Proteins 0.000 claims description 6
• 108010078239 Chemokine CX3CL1 Proteins 0.000 claims description 6
• 102000013818 Fractalkine Human genes 0.000 claims description 6
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 claims description 6
• 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 claims description 6
• 102000000589 Interleukin-1 Human genes 0.000 claims description 6
• 108010002352 Interleukin-1 Proteins 0.000 claims description 6
• 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 claims description 6
• 101710144554 Interleukin-1 receptor antagonist protein Proteins 0.000 claims description 6
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 6
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 6
• 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 claims description 6
• 239000003795 chemical substances by application Substances 0.000 claims description 6
• 230000000415 inactivating effect Effects 0.000 claims description 6
• 239000000758 substrate Substances 0.000 claims description 6
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 6
• 102100025279 C-X-C motif chemokine 11 Human genes 0.000 claims description 5
• 108010029697 CD40 Ligand Proteins 0.000 claims description 5
• 101150013553 CD40 gene Proteins 0.000 claims description 5
• 102100032937 CD40 ligand Human genes 0.000 claims description 5
• 108010051696 Growth Hormone Proteins 0.000 claims description 5
• 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 5
• 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 claims description 5
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 5
• 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 claims description 5
• 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 claims description 5
• 230000004913 activation Effects 0.000 claims description 5
• 239000000122 growth hormone Substances 0.000 claims description 5
• 102000058223 human VEGFA Human genes 0.000 claims description 5
• 208000010392 Bone Fractures Diseases 0.000 claims description 4
• 102000003729 Neprilysin Human genes 0.000 claims description 4
• 108090000028 Neprilysin Proteins 0.000 claims description 4
• 239000006143 cell culture medium Substances 0.000 claims description 4
• 108010008978 Chemokine CXCL10 Proteins 0.000 claims description 3
• 102000006579 Chemokine CXCL10 Human genes 0.000 claims description 3
• 208000011231 Crohn disease Diseases 0.000 claims description 3
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 3
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 3
• 208000004221 Multiple Trauma Diseases 0.000 claims description 3
• 208000023637 Multiple injury Diseases 0.000 claims description 3
• 208000006011 Stroke Diseases 0.000 claims description 3
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 3
• 238000004873 anchoring Methods 0.000 claims description 3
• 206010012601 diabetes mellitus Diseases 0.000 claims description 3
• 210000002082 fibula Anatomy 0.000 claims description 3
• 210000001624 hip Anatomy 0.000 claims description 3
• 206010025135 lupus erythematosus Diseases 0.000 claims description 3
• 210000004373 mandible Anatomy 0.000 claims description 3
• 210000001872 metatarsal bone Anatomy 0.000 claims description 3
• 208000031225 myocardial ischemia Diseases 0.000 claims description 3
• 210000002320 radius Anatomy 0.000 claims description 3
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 3
• 238000001179 sorption measurement Methods 0.000 claims description 3
• 210000000278 spinal cord Anatomy 0.000 claims description 3
• 210000001562 sternum Anatomy 0.000 claims description 3
• 210000000623 ulna Anatomy 0.000 claims description 3
• 101710098272 C-X-C motif chemokine 11 Proteins 0.000 claims description 2
• 108010041308 Endothelial Growth Factors Proteins 0.000 claims description 2
• 230000002255 enzymatic effect Effects 0.000 claims description 2
• 102100021866 Hepatocyte growth factor Human genes 0.000 claims 2
• 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 claims 2
• 102000004890 Interleukin-8 Human genes 0.000 claims 2
• 102000018997 Growth Hormone Human genes 0.000 claims 1
• 230000010478 bone regeneration Effects 0.000 abstract description 14
• 230000004936 stimulating effect Effects 0.000 abstract description 5
• 229940088598 enzyme Drugs 0.000 description 109
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 47
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 45
• 208000027418 Wounds and injury Diseases 0.000 description 32
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 30
• 102100025304 Integrin beta-1 Human genes 0.000 description 30
• 239000012091 fetal bovine serum Substances 0.000 description 30
• 208000014674 injury Diseases 0.000 description 29
• 230000008569 process Effects 0.000 description 27
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 24
• 230000001172 regenerating effect Effects 0.000 description 24
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 23
• 238000000926 separation method Methods 0.000 description 21
• 230000028327 secretion Effects 0.000 description 20
• 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 19
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 19
• 102100026236 Interleukin-8 Human genes 0.000 description 19
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 19
• 210000002889 endothelial cell Anatomy 0.000 description 19
• 239000000843 powder Substances 0.000 description 19
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
• 239000002253 acid Substances 0.000 description 18
• 239000001963 growth medium Substances 0.000 description 18
• 210000003954 umbilical cord Anatomy 0.000 description 18
• 210000004369 blood Anatomy 0.000 description 17
• 239000008280 blood Substances 0.000 description 17
• 108010081589 Becaplermin Proteins 0.000 description 16
• 239000000316 bone substitute Substances 0.000 description 16
• 239000007788 liquid Substances 0.000 description 16
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
• 238000004458 analytical method Methods 0.000 description 15
• 229960002424 collagenase Drugs 0.000 description 15
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 15
• 230000001464 adherent effect Effects 0.000 description 14
• 230000000694 effects Effects 0.000 description 14
• 239000002245 particle Substances 0.000 description 14
• 241000894006 Bacteria Species 0.000 description 13
• 238000011534 incubation Methods 0.000 description 13
• 210000000515 tooth Anatomy 0.000 description 13
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 12
• 239000007760 Iscove's Modified Dulbecco's Medium Substances 0.000 description 12
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 12
• 229930182816 L-glutamine Natural products 0.000 description 12
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 12
• 239000012894 fetal calf serum Substances 0.000 description 12
• 230000003394 haemopoietic effect Effects 0.000 description 12
• 229920000669 heparin Polymers 0.000 description 12
• 229960002897 heparin Drugs 0.000 description 12
• 239000006249 magnetic particle Substances 0.000 description 12
• 229910052757 nitrogen Inorganic materials 0.000 description 12
• 239000008188 pellet Substances 0.000 description 12
• 230000001629 suppression Effects 0.000 description 12
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 11
• 241001465754 Metazoa Species 0.000 description 11
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 11
• 229930182555 Penicillin Natural products 0.000 description 11
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 11
• 238000004132 cross linking Methods 0.000 description 11
• 238000000605 extraction Methods 0.000 description 11
• 230000005764 inhibitory process Effects 0.000 description 11
• 210000002901 mesenchymal stem cell Anatomy 0.000 description 11
• 238000003801 milling Methods 0.000 description 11
• 229940049954 penicillin Drugs 0.000 description 11
• 210000002966 serum Anatomy 0.000 description 11
• 102100036537 von Willebrand factor Human genes 0.000 description 11
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 10
• 230000000735 allogeneic effect Effects 0.000 description 10
• 235000011089 carbon dioxide Nutrition 0.000 description 10
• MURGITYSBWUQTI-UHFFFAOYSA-N fluorescin Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C21 MURGITYSBWUQTI-UHFFFAOYSA-N 0.000 description 10
• 238000002347 injection Methods 0.000 description 10
• 239000007924 injection Substances 0.000 description 10
• 229910052500 inorganic mineral Inorganic materials 0.000 description 10
• 238000005304 joining Methods 0.000 description 10
• 235000010755 mineral Nutrition 0.000 description 10
• 239000011707 mineral Substances 0.000 description 10
• 238000002156 mixing Methods 0.000 description 10
• 239000004017 serum-free culture medium Substances 0.000 description 10
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
• 241000196324 Embryophyta Species 0.000 description 9
• 206010016654 Fibrosis Diseases 0.000 description 9
• 241000233866 Fungi Species 0.000 description 9
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 9
• 102100040247 Tumor necrosis factor Human genes 0.000 description 9
• 230000002424 anti-apoptotic effect Effects 0.000 description 9
• 230000000975 bioactive effect Effects 0.000 description 9
• 230000021615 conjugation Effects 0.000 description 9
• 210000004443 dendritic cell Anatomy 0.000 description 9
• 239000003814 drug Substances 0.000 description 9
• 230000004761 fibrosis Effects 0.000 description 9
• 238000000684 flow cytometry Methods 0.000 description 9
• 210000002865 immune cell Anatomy 0.000 description 9
• 210000004786 perivascular cell Anatomy 0.000 description 9
• 210000002826 placenta Anatomy 0.000 description 9
• 230000035755 proliferation Effects 0.000 description 9
• 239000006228 supernatant Substances 0.000 description 9
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 8
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 8
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 8
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 8
• 230000015572 biosynthetic process Effects 0.000 description 8
• 239000002975 chemoattractant Substances 0.000 description 8
• 210000003414 extremity Anatomy 0.000 description 8
• 238000007710 freezing Methods 0.000 description 8
• 230000008014 freezing Effects 0.000 description 8
• 238000001727 in vivo Methods 0.000 description 8
• 210000005087 mononuclear cell Anatomy 0.000 description 8
• 210000003668 pericyte Anatomy 0.000 description 8
• 230000035899 viability Effects 0.000 description 8
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 7
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 7
• 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 7
• 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 7
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 7
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 7
• 108091008606 PDGF receptors Proteins 0.000 description 7
• 206010052428 Wound Diseases 0.000 description 7
• 235000001014 amino acid Nutrition 0.000 description 7
• 229940024606 amino acid Drugs 0.000 description 7
• 230000002491 angiogenic effect Effects 0.000 description 7
• 210000002744 extracellular matrix Anatomy 0.000 description 7
• 230000006870 function Effects 0.000 description 7
• 239000003102 growth factor Substances 0.000 description 7
• 239000007943 implant Substances 0.000 description 7
• 210000002540 macrophage Anatomy 0.000 description 7
• 239000011859 microparticle Substances 0.000 description 7
• 239000000523 sample Substances 0.000 description 7
• 239000013589 supplement Substances 0.000 description 7
• 230000017423 tissue regeneration Effects 0.000 description 7
• 108090001008 Avidin Proteins 0.000 description 6
• 102100036848 C-C motif chemokine 20 Human genes 0.000 description 6
• 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 6
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
• KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 6
• 108091006905 Human Serum Albumin Proteins 0.000 description 6
• 102000008100 Human Serum Albumin Human genes 0.000 description 6
• 102000000588 Interleukin-2 Human genes 0.000 description 6
• 108010002350 Interleukin-2 Proteins 0.000 description 6
• 102000015696 Interleukins Human genes 0.000 description 6
• 108010063738 Interleukins Proteins 0.000 description 6
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 6
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 6
• 208000006735 Periostitis Diseases 0.000 description 6
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
• 230000006052 T cell proliferation Effects 0.000 description 6
• 108090000631 Trypsin Proteins 0.000 description 6
• 102000004142 Trypsin Human genes 0.000 description 6
• 150000001413 amino acids Chemical class 0.000 description 6
• 230000003510 anti-fibrotic effect Effects 0.000 description 6
• 210000003719 b-lymphocyte Anatomy 0.000 description 6
• 229960002685 biotin Drugs 0.000 description 6
• 235000020958 biotin Nutrition 0.000 description 6
• 239000011616 biotin Substances 0.000 description 6
• 229940098773 bovine serum albumin Drugs 0.000 description 6
• 239000011575 calcium Substances 0.000 description 6
• 239000003054 catalyst Substances 0.000 description 6
• 210000002808 connective tissue Anatomy 0.000 description 6
• 230000004069 differentiation Effects 0.000 description 6
• 238000001990 intravenous administration Methods 0.000 description 6
• 125000005647 linker group Chemical group 0.000 description 6
• 210000004185 liver Anatomy 0.000 description 6
• 210000003460 periosteum Anatomy 0.000 description 6
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 6
• 238000011069 regeneration method Methods 0.000 description 6
• 210000002027 skeletal muscle Anatomy 0.000 description 6
• 238000001228 spectrum Methods 0.000 description 6
• 238000010186 staining Methods 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• 208000037816 tissue injury Diseases 0.000 description 6
• 239000012588 trypsin Substances 0.000 description 6
• 229960001322 trypsin Drugs 0.000 description 6
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
• 102000004127 Cytokines Human genes 0.000 description 5
• 108090000695 Cytokines Proteins 0.000 description 5
• 108010071289 Factor XIII Proteins 0.000 description 5
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 5
• 210000000577 adipose tissue Anatomy 0.000 description 5
• 210000004381 amniotic fluid Anatomy 0.000 description 5
• 229940088710 antibiotic agent Drugs 0.000 description 5
• 229910052586 apatite Inorganic materials 0.000 description 5
• 229910052791 calcium Inorganic materials 0.000 description 5
• 239000002131 composite material Substances 0.000 description 5
• 210000004489 deciduous teeth Anatomy 0.000 description 5
• 239000008103 glucose Substances 0.000 description 5
• 238000007654 immersion Methods 0.000 description 5
• 238000002955 isolation Methods 0.000 description 5
• 210000004072 lung Anatomy 0.000 description 5
• 229920005615 natural polymer Polymers 0.000 description 5
• 210000000496 pancreas Anatomy 0.000 description 5
• VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 5
• 229920000747 poly(lactic acid) Polymers 0.000 description 5
• 238000004321 preservation Methods 0.000 description 5
• 230000000770 proinflammatory effect Effects 0.000 description 5
• 239000008223 sterile water Substances 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 210000001258 synovial membrane Anatomy 0.000 description 5
• 229920001059 synthetic polymer Polymers 0.000 description 5
• 238000011285 therapeutic regimen Methods 0.000 description 5
• 238000011282 treatment Methods 0.000 description 5
• 229910000391 tricalcium phosphate Inorganic materials 0.000 description 5
• 229940078499 tricalcium phosphate Drugs 0.000 description 5
• 210000005166 vasculature Anatomy 0.000 description 5
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 4
• 241000193159 Hathewaya histolytica Species 0.000 description 4
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 4
• 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 4
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 4
• 102100038803 Somatotropin Human genes 0.000 description 4
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
• 239000000969 carrier Substances 0.000 description 4
• 230000010261 cell growth Effects 0.000 description 4
• 230000004663 cell proliferation Effects 0.000 description 4
• 238000000432 density-gradient centrifugation Methods 0.000 description 4
• 239000004053 dental implant Substances 0.000 description 4
• 238000011049 filling Methods 0.000 description 4
• 210000003714 granulocyte Anatomy 0.000 description 4
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
• 238000000338 in vitro Methods 0.000 description 4
• 210000004969 inflammatory cell Anatomy 0.000 description 4
• 238000001802 infusion Methods 0.000 description 4
• 230000003902 lesion Effects 0.000 description 4
• 238000007885 magnetic separation Methods 0.000 description 4
• 210000001616 monocyte Anatomy 0.000 description 4
• 235000015097 nutrients Nutrition 0.000 description 4
• 239000001301 oxygen Substances 0.000 description 4
• 229910052760 oxygen Inorganic materials 0.000 description 4
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
• 230000002265 prevention Effects 0.000 description 4
• 108090000765 processed proteins & peptides Proteins 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 230000008929 regeneration Effects 0.000 description 4
• 230000008439 repair process Effects 0.000 description 4
• 150000003839 salts Chemical class 0.000 description 4
• 230000037390 scarring Effects 0.000 description 4
• 239000007787 solid Substances 0.000 description 4
• 239000000725 suspension Substances 0.000 description 4
• 229940124597 therapeutic agent Drugs 0.000 description 4
• 125000003396 thiol group Chemical group [H]S* 0.000 description 4
• 210000004291 uterus Anatomy 0.000 description 4
• JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 description 3
• WNDKIGQUFDOYIB-UHFFFAOYSA-N 1-hydroxypyrrolidine-2,5-dione;propanoic acid Chemical compound CCC(O)=O.ON1C(=O)CCC1=O WNDKIGQUFDOYIB-UHFFFAOYSA-N 0.000 description 3
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
• 102000004008 5'-Nucleotidase Human genes 0.000 description 3
• 108700004024 5'-Nucleotidase Proteins 0.000 description 3
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 3
• 102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 3
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 3
• 102100033620 Calponin-1 Human genes 0.000 description 3
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 3
• LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 3
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 3
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 3
• 102100020997 Fractalkine Human genes 0.000 description 3
• 229920002683 Glycosaminoglycan Polymers 0.000 description 3
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 3
• 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 description 3
• 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 3
• 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 3
• 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 3
• 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 3
• 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 description 3
• 101000945318 Homo sapiens Calponin-1 Proteins 0.000 description 3
• 101000854520 Homo sapiens Fractalkine Proteins 0.000 description 3
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 3
• 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 3
• 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 3
• 101000652736 Homo sapiens Transgelin Proteins 0.000 description 3
• 108010013214 Hyaluronan Receptors Proteins 0.000 description 3
• 206010021143 Hypoxia Diseases 0.000 description 3
• 102000043129 MHC class I family Human genes 0.000 description 3
• 108091054437 MHC class I family Proteins 0.000 description 3
• 102000043131 MHC class II family Human genes 0.000 description 3
• 108091054438 MHC class II family Proteins 0.000 description 3
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
• 108010004729 Phycoerythrin Proteins 0.000 description 3
• 206010061363 Skeletal injury Diseases 0.000 description 3
• 108010090804 Streptavidin Proteins 0.000 description 3
• 238000001042 affinity chromatography Methods 0.000 description 3
• 150000001447 alkali salts Chemical class 0.000 description 3
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 230000000844 anti-bacterial effect Effects 0.000 description 3
• 239000003429 antifungal agent Substances 0.000 description 3
• 229940121375 antifungal agent Drugs 0.000 description 3
• 210000000612 antigen-presenting cell Anatomy 0.000 description 3
• 238000000149 argon plasma sintering Methods 0.000 description 3
• 230000003190 augmentative effect Effects 0.000 description 3
• 239000007640 basal medium Substances 0.000 description 3
• 210000003651 basophil Anatomy 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 239000003633 blood substitute Substances 0.000 description 3
• 230000036770 blood supply Effects 0.000 description 3
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
• 239000004327 boric acid Substances 0.000 description 3
• 210000000845 cartilage Anatomy 0.000 description 3
• 230000003197 catalytic effect Effects 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 239000012141 concentrate Substances 0.000 description 3
• 239000003431 cross linking reagent Substances 0.000 description 3
• 230000034994 death Effects 0.000 description 3
• 230000001627 detrimental effect Effects 0.000 description 3
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 3
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 3
• LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 3
• 229960005156 digoxin Drugs 0.000 description 3
• LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 239000000975 dye Substances 0.000 description 3
• 210000003979 eosinophil Anatomy 0.000 description 3
• 229940126864 fibroblast growth factor Drugs 0.000 description 3
• 230000003328 fibroblastic effect Effects 0.000 description 3
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
• 230000005484 gravity Effects 0.000 description 3
• 230000035876 healing Effects 0.000 description 3
• 210000002443 helper t lymphocyte Anatomy 0.000 description 3
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 3
• 230000011132 hemopoiesis Effects 0.000 description 3
• 230000001146 hypoxic effect Effects 0.000 description 3
• 230000016784 immunoglobulin production Effects 0.000 description 3
• 238000000099 in vitro assay Methods 0.000 description 3
• 230000000302 ischemic effect Effects 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 239000006166 lysate Substances 0.000 description 3
• 238000012423 maintenance Methods 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 238000002483 medication Methods 0.000 description 3
• 210000000822 natural killer cell Anatomy 0.000 description 3
• 239000013642 negative control Substances 0.000 description 3
• 210000000440 neutrophil Anatomy 0.000 description 3
• 229910017604 nitric acid Inorganic materials 0.000 description 3
• 125000006501 nitrophenyl group Chemical group 0.000 description 3
• 238000010883 osseointegration Methods 0.000 description 3
• 238000004091 panning Methods 0.000 description 3
• 244000052769 pathogen Species 0.000 description 3
• NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 3
• 108060006184 phycobiliprotein Proteins 0.000 description 3
• 210000004180 plasmocyte Anatomy 0.000 description 3
• 210000004623 platelet-rich plasma Anatomy 0.000 description 3
• 229920001184 polypeptide Polymers 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 230000001023 pro-angiogenic effect Effects 0.000 description 3
• 102000004196 processed proteins & peptides Human genes 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 230000007115 recruitment Effects 0.000 description 3
• 210000003289 regulatory T cell Anatomy 0.000 description 3
• 239000012266 salt solution Substances 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 230000001954 sterilising effect Effects 0.000 description 3
• 238000003860 storage Methods 0.000 description 3
• JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 description 3
• 230000004083 survival effect Effects 0.000 description 3
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 230000001131 transforming effect Effects 0.000 description 3
• 230000007704 transition Effects 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• LQILVUYCDHSGEU-UHFFFAOYSA-N 4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexane-1-carboxylic acid Chemical compound C1CC(C(=O)O)CCC1CN1C(=O)C=CC1=O LQILVUYCDHSGEU-UHFFFAOYSA-N 0.000 description 2
• 229930183010 Amphotericin Natural products 0.000 description 2
• QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 2
• 239000004475 Arginine Substances 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 102000019034 Chemokines Human genes 0.000 description 2
• 108010012236 Chemokines Proteins 0.000 description 2
• 108010035532 Collagen Proteins 0.000 description 2
• 102000008186 Collagen Human genes 0.000 description 2
• 208000034423 Delivery Diseases 0.000 description 2
• 102000005593 Endopeptidases Human genes 0.000 description 2
• 108010059378 Endopeptidases Proteins 0.000 description 2
• 108010091443 Exopeptidases Proteins 0.000 description 2
• 102000018389 Exopeptidases Human genes 0.000 description 2
• 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 description 2
• 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
• 102000003843 Metalloendopeptidases Human genes 0.000 description 2
• 108090000131 Metalloendopeptidases Proteins 0.000 description 2
• 230000006051 NK cell activation Effects 0.000 description 2
• 206010070834 Sensitisation Diseases 0.000 description 2
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
• RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
• RDFCSSHDJSZMTQ-ZDUSSCGKSA-N Tos-Lys-CH2Cl Chemical compound CC1=CC=C(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)C=C1 RDFCSSHDJSZMTQ-ZDUSSCGKSA-N 0.000 description 2
• 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 2
• DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 2
• 229940009444 amphotericin Drugs 0.000 description 2
• 230000030741 antigen processing and presentation Effects 0.000 description 2
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
• 238000011882 arthroplasty Methods 0.000 description 2
• 230000001363 autoimmune Effects 0.000 description 2
• 230000005784 autoimmunity Effects 0.000 description 2
• 239000007853 buffer solution Substances 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 239000002458 cell surface marker Substances 0.000 description 2
• 230000033077 cellular process Effects 0.000 description 2
• 230000001889 chemoattractive effect Effects 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 238000004140 cleaning Methods 0.000 description 2
• 239000011248 coating agent Substances 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 2
• 229920001436 collagen Polymers 0.000 description 2
• 239000013078 crystal Substances 0.000 description 2
• 235000018417 cysteine Nutrition 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 238000005115 demineralization Methods 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 2
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
• 229940066758 endopeptidases Drugs 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
• 210000002391 femur head Anatomy 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
• 229960005051 fluostigmine Drugs 0.000 description 2
• 150000004676 glycans Chemical class 0.000 description 2
• 210000001981 hip bone Anatomy 0.000 description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
• 230000028993 immune response Effects 0.000 description 2
• 230000037451 immune surveillance Effects 0.000 description 2
• 230000001506 immunosuppresive effect Effects 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 210000003127 knee Anatomy 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 238000010338 mechanical breakdown Methods 0.000 description 2
• 239000003226 mitogen Substances 0.000 description 2
• 210000000651 myofibroblast Anatomy 0.000 description 2
• 230000000399 orthopedic effect Effects 0.000 description 2
• 230000002188 osteogenic effect Effects 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 230000001766 physiological effect Effects 0.000 description 2
• 229920001282 polysaccharide Polymers 0.000 description 2
• 239000005017 polysaccharide Substances 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• 230000002062 proliferating effect Effects 0.000 description 2
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 238000003757 reverse transcription PCR Methods 0.000 description 2
• 230000008313 sensitization Effects 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 210000003491 skin Anatomy 0.000 description 2
• 210000004872 soft tissue Anatomy 0.000 description 2
• 239000003206 sterilizing agent Substances 0.000 description 2
• 230000003319 supportive effect Effects 0.000 description 2
• 239000010936 titanium Substances 0.000 description 2
• 229910052719 titanium Inorganic materials 0.000 description 2
• 210000004746 tooth root Anatomy 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 238000012384 transportation and delivery Methods 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• 210000003556 vascular endothelial cell Anatomy 0.000 description 2
• 230000000982 vasogenic effect Effects 0.000 description 2
• 230000029663 wound healing Effects 0.000 description 2
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
• IAJILQKETJEXLJ-KLVWXMOXSA-N (2s,3r,4r,5r)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid Chemical compound O=C[C@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-KLVWXMOXSA-N 0.000 description 1
• MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
• 108091005508 Acid proteases Proteins 0.000 description 1
• 108010075348 Activated-Leukocyte Cell Adhesion Molecule Proteins 0.000 description 1
• 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
• 102100022712 Alpha-1-antitrypsin Human genes 0.000 description 1
• 102000004400 Aminopeptidases Human genes 0.000 description 1
• 108090000915 Aminopeptidases Proteins 0.000 description 1
• 108010039627 Aprotinin Proteins 0.000 description 1
• 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
• 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
• VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 description 1
• VGGGPCQERPFHOB-UHFFFAOYSA-N Bestatin Natural products CC(C)CC(C(O)=O)NC(=O)C(O)C(N)CC1=CC=CC=C1 VGGGPCQERPFHOB-UHFFFAOYSA-N 0.000 description 1
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108091016585 CD44 antigen Proteins 0.000 description 1
• 101000898643 Candida albicans Vacuolar aspartic protease Proteins 0.000 description 1
• 101000898783 Candida tropicalis Candidapepsin Proteins 0.000 description 1
• 102000000496 Carboxypeptidases A Human genes 0.000 description 1
• 108010080937 Carboxypeptidases A Proteins 0.000 description 1
• 229920002567 Chondroitin Polymers 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• 101000898784 Cryphonectria parasitica Endothiapepsin Proteins 0.000 description 1
• JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
• 108010024212 E-Selectin Proteins 0.000 description 1
• 102100023471 E-selectin Human genes 0.000 description 1
• LTLYEAJONXGNFG-DCAQKATOSA-N E64 Chemical compound NC(=N)NCCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O LTLYEAJONXGNFG-DCAQKATOSA-N 0.000 description 1
• 108010036395 Endoglin Proteins 0.000 description 1
• 241000289695 Eutheria Species 0.000 description 1
• 239000009484 FIBS Substances 0.000 description 1
• 108010073385 Fibrin Proteins 0.000 description 1
• 102000009123 Fibrin Human genes 0.000 description 1
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
• 102100037362 Fibronectin Human genes 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 108010009202 Growth Factor Receptors Proteins 0.000 description 1
• 102000009465 Growth Factor Receptors Human genes 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• 101001078158 Homo sapiens Integrin alpha-1 Proteins 0.000 description 1
• 101001078133 Homo sapiens Integrin alpha-2 Proteins 0.000 description 1
• 101000994378 Homo sapiens Integrin alpha-3 Proteins 0.000 description 1
• 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 1
• 101000994369 Homo sapiens Integrin alpha-5 Proteins 0.000 description 1
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
• 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
• 101000599862 Homo sapiens Intercellular adhesion molecule 3 Proteins 0.000 description 1
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 1
• 101000610551 Homo sapiens Prominin-1 Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• 206010020649 Hyperkeratosis Diseases 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102100025323 Integrin alpha-1 Human genes 0.000 description 1
• 102100025305 Integrin alpha-2 Human genes 0.000 description 1
• 102100032819 Integrin alpha-3 Human genes 0.000 description 1
• 102100032818 Integrin alpha-4 Human genes 0.000 description 1
• 102100032817 Integrin alpha-5 Human genes 0.000 description 1
• 102100022338 Integrin alpha-M Human genes 0.000 description 1
• 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 description 1
• 101710148794 Intercellular adhesion molecule 2 Proteins 0.000 description 1
• 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• 102100033467 L-selectin Human genes 0.000 description 1
• GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 102000005612 Metalloexopeptidases Human genes 0.000 description 1
• 108010045057 Metalloexopeptidases Proteins 0.000 description 1
• 206010028851 Necrosis Diseases 0.000 description 1
• 102100037591 Neuroserpin Human genes 0.000 description 1
• 108090000573 Osteocalcin Proteins 0.000 description 1
• 102000004067 Osteocalcin Human genes 0.000 description 1
• 102000004264 Osteopontin Human genes 0.000 description 1
• 108010081689 Osteopontin Proteins 0.000 description 1
• 101150044441 PECAM1 gene Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 1
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 1
• 229920000954 Polyglycolide Polymers 0.000 description 1
• 102100040120 Prominin-1 Human genes 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
• 108010067787 Proteoglycans Proteins 0.000 description 1
• 102000016611 Proteoglycans Human genes 0.000 description 1
• 208000002607 Pseudarthrosis Diseases 0.000 description 1
• 101000933133 Rhizopus niveus Rhizopuspepsin-1 Proteins 0.000 description 1
• 101000910082 Rhizopus niveus Rhizopuspepsin-2 Proteins 0.000 description 1
• 101000910079 Rhizopus niveus Rhizopuspepsin-3 Proteins 0.000 description 1
• 101000910086 Rhizopus niveus Rhizopuspepsin-4 Proteins 0.000 description 1
• 101000910088 Rhizopus niveus Rhizopuspepsin-5 Proteins 0.000 description 1
• 239000008156 Ringer's lactate solution Substances 0.000 description 1
• 101000898773 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharopepsin Proteins 0.000 description 1
• 108090000184 Selectins Proteins 0.000 description 1
• 102000003800 Selectins Human genes 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 102000035100 Threonine proteases Human genes 0.000 description 1
• 108091005501 Threonine proteases Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 108010033576 Transferrin Receptors Proteins 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 102000019997 adhesion receptor Human genes 0.000 description 1
• 108010013985 adhesion receptor Proteins 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 230000002293 adipogenic effect Effects 0.000 description 1
• 108010091628 alpha 1-Antichymotrypsin Proteins 0.000 description 1
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 239000004019 antithrombin Substances 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 229960004405 aprotinin Drugs 0.000 description 1
• 210000001188 articular cartilage Anatomy 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 230000003416 augmentation Effects 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 230000008468 bone growth Effects 0.000 description 1
• 238000009583 bone marrow aspiration Methods 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 description 1
• ZEWYCNBZMPELPF-UHFFFAOYSA-J calcium;potassium;sodium;2-hydroxypropanoic acid;sodium;tetrachloride Chemical compound [Na].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[Ca+2].CC(O)C(O)=O ZEWYCNBZMPELPF-UHFFFAOYSA-J 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 230000003399 chemotactic effect Effects 0.000 description 1
• 235000012000 cholesterol Nutrition 0.000 description 1
• 230000002648 chondrogenic effect Effects 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 229910017052 cobalt Inorganic materials 0.000 description 1
• 239000010941 cobalt Substances 0.000 description 1
• GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
• 229910001429 cobalt ion Inorganic materials 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000001054 cortical effect Effects 0.000 description 1
• 239000002577 cryoprotective agent Substances 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000002328 demineralizing effect Effects 0.000 description 1
• 230000001687 destabilization Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• 125000000600 disaccharide group Chemical group 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 229950003499 fibrin Drugs 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• 150000002402 hexoses Chemical class 0.000 description 1
• 238000011540 hip replacement Methods 0.000 description 1
• 150000003840 hydrochlorides Chemical class 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000003301 hydrolyzing effect Effects 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 230000008975 immunomodulatory function Effects 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 1
• 108040006856 interleukin-3 receptor activity proteins Proteins 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 210000001847 jaw Anatomy 0.000 description 1
• 235000015110 jellies Nutrition 0.000 description 1
• 239000008274 jelly Substances 0.000 description 1
• RVPVRDXYQKGNMQ-UHFFFAOYSA-N lead(2+) Chemical compound [Pb+2] RVPVRDXYQKGNMQ-UHFFFAOYSA-N 0.000 description 1
• GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
• 108010052968 leupeptin Proteins 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 210000004324 lymphatic system Anatomy 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 150000002690 malonic acid derivatives Chemical class 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 230000007721 medicinal effect Effects 0.000 description 1
• BQPIGGFYSBELGY-UHFFFAOYSA-N mercury(2+) Chemical compound [Hg+2] BQPIGGFYSBELGY-UHFFFAOYSA-N 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 230000002297 mitogenic effect Effects 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 230000001114 myogenic effect Effects 0.000 description 1
• 230000017074 necrotic cell death Effects 0.000 description 1
• 210000003061 neural cell Anatomy 0.000 description 1
• 108010080874 neuroserpin Proteins 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 230000004072 osteoblast differentiation Effects 0.000 description 1
• 210000002997 osteoclast Anatomy 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• 235000021317 phosphate Nutrition 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 210000002381 plasma Anatomy 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 231100000241 scar Toxicity 0.000 description 1
• 238000002791 soaking Methods 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 108010059339 submandibular proteinase A Proteins 0.000 description 1
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 210000002435 tendon Anatomy 0.000 description 1
• TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 229950009811 ubenimex Drugs 0.000 description 1
• 230000007998 vessel formation Effects 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1